Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker
Figure 5. Analysis of XCL2 and the tumor microenvironment in four cancer types with top correlation coefficients, including BRCA, GBM, KIRC, and THCA (A–D).